Although we determined that a wide range of Tie2+ ECs and HL cells are not required for the antiatherogenic actions of semaglutide, our studies did not identify the precise GLP-1R+ cells required for GLP-1RAs to attenuate atherosclerosis. The gene discussed is GLP1R; the disease is atherosclerosis.